Belgium· BE-AMP-SAM204145-00

Virgan 1.5 mg/g

A ganciclovir product containing ganciclovir, registered in Belgium by Laboratoires Théa. The same ATC class is registered in 9 of our 19 countries.

ATC S01AD09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVirgan 1.5 mg/gATCS01AD09REGISTER NO.BE-AMP-SAM204145-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Ganciclovir is registered in 9 of 19 countries.

Countries holding a registration under ATC S01AD09 (ganciclovir), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Ganciclovir · ATC S01AD09

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ganciclovir
Manufacturer
Laboratoires Théa
Country
Belgium (BE)
ATC code
S01AD09
ATC class
Ganciclovir
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0770396
  • be_apb
    1649458
    EUR 16.61

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ganciclovir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Cymevene, Ganciclovir Oresund Pharma
  • Bulgaria · Ганцикловир Ромфарм
  • Czechia · Cymevene, Virgan
  • Germany · Cymeven I.V., Ganciclovir Accord
  • Denmark · Cymevene, Ganciclovir Oresund Pharma
  • Spain · Cymevene, Ganciclovir Accord
  • Finland · Cymevene, Ganciclovir Bioglan
  • France · Cymevan, Ganciclovir Hikma
  • United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
  • Greece · Gancilen, Virgan
  • Croatia · Cymevene
  • Hungary · Cymevene, Ganciclovir Rompharm
  • Ireland · Cymevene
  • Italy · Citovirax, Ganciclovir Accord
  • Luxembourg · Cymevene, Virgan
  • Netherlands · Cymevene, Ganciclovir Sandoz
  • Norway · Cymevene, Ganciclovir Bioglan
  • Poland · Cymevene, Ganciclovir Accord
  • Portugal · Cymevene, Ganciclovir Accord
  • Romania · Ganciclovir Rompharm, Virgan
  • Sweden · Cymevene, Ganciclovir Bioglan
  • Slovakia · Cymevene

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/66ebf1d0-854e-48b4-96d4-124352e4e43e
GET /v1/drugs/66ebf1d0-854e-48b4-96d4-124352e4e43e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye gel",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Virgan 1.5 mg/g",
  "name_fr": "Virgan 1.5 mg/g",
  "name_nl": "Virgan 1.5 mg/g",
  "amp_code": "SAM204145-00",
  "strengths": [
    "1.5000",
    "0.0750",
    "1.5000",
    "50.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Ganciclovir",
    "Benzalkonium Chloride",
    "Sodium Hydroxide",
    "Sorbitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ganciclovir",
  "authorisation_numbers": [
    "BE204145"
  ]
}

See everything about ganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.